Results 161 to 170 of about 386,145 (366)

iKlax: a New Musical Audio Format for Active Listening

open access: yes, 2008
In this paper, we are presenting a new model for interactive music. Unlike most interactive systems, our model is based on file organization, but does not require digital audio treatments.
Desainte-Catherine, Myriam   +3 more
core   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham   +21 more
wiley   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

open access: yesMolecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan   +9 more
wiley   +1 more source

Cultural Code of Evolution: Spirituality, Creativity, Morality, Ethics

open access: yesCadmus
Humanity faces unprecedented global challenges that demand an integrative cultural paradigm uniting spirituality, creativity, morality, and ethics.
Natalia Rojcovscaia-Tumaha
doaj  

Deep Composer Classification Using Symbolic Representation. [PDF]

open access: green, 2020
Hye Yoon Lee   +4 more
openalex  

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy